Gliosarcoma
Symptoms, Doctors, Treatments, Advances & More

Gliosarcoma Overview

Save information for later
Sign Up

Learn About Gliosarcoma

View Main Condition: Brain Tumor

What is the definition of Gliosarcoma?
Gliosarcoma is a rare type of brain tumor that develops from glial cells, which are specialized cells that surround and support neurons (nerve cells). Unlike gliomas, gliosarcomas have a higher likelihood to spread to the lymph nodes, lungs, and liver. 
What are the causes of Gliosarcoma?
The cause of gliosarcomas is still unknown. However, gliosarcomas generally tend to be more common in adults than children. Men are also more likely to develop gliosarcomas than women.
What are the symptoms of Gliosarcoma?
The symptoms of gliosarcomas primarily depend on the tumor's location as well as how much the tumor has spread. Common symptoms include headaches, memory difficulties, fatigue, numbness, balance issues, and seizures. 
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Gliosarcoma?
Treatment for gliosarcoma may include surgery, radiation therapy, and/or chemotherapy. Surgery to remove as much of the tumor as possible is generally the first step in treating gliosarcoma. However, if a tumor is located near a sensitive area in the brain, surgery may not be possible at all. Radiation therapy often follows surgery for the treatment of gliosarcoma. Radiation therapy involves the use of high-energy beams, including X-rays or protons, to destroy tumor cells. Chemotherapy involves the use of drugs, either taken orally or injected through a vein, to kill tumor cells. Chemotherapy is often used in combination with radiation therapy.
Who are the top Gliosarcoma Local Doctors?
Elite in Gliosarcoma
Elite in Gliosarcoma
Referral may be required

Adolescent And Young Adult Neuro-Oncology Clinic

400 Parnassus Ave # 8, 
San Francisco, CA 
415-353-7500
Languages Spoken:
English
See accepted insurances
Offers Telehealth

John De Groot is a Neurologist practicing medicine in San Francisco, California. Dr. De Groot is rated as an Elite provider by MediFind in the treatment of Gliosarcoma. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, and Brain Tumor.

Elite in Gliosarcoma
Dr. Andrew E. Sloan
Neurosurgery
Elite in Gliosarcoma
Dr. Andrew E. Sloan
Neurosurgery
Referral may be required

Clinical Neuroscience Institute At Miami Valley Hospital South Campus

2300 Miami Valley Dr Ste 550, 
Centerville, OH 
937-668-7219
Languages Spoken:
English, Haitian Creole, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Andrew Sloan is a Neurosurgery provider practicing medicine in Centerville, Ohio. Dr. Sloan is rated as an Elite provider by MediFind in the treatment of Gliosarcoma. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, Awake Craniotomy, and Gamma Knife Radiosurgery. Dr. Sloan is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Gliosarcoma
Elite in Gliosarcoma
Referral may be required

UT MD Anderson Cancer Center

1515 Holcombe Blvd, 
Houston, TX 
713-792-6600
Experience:
17+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Shiao-pei Weathers is a Neurologist practicing medicine in Houston, Texas. She has been practicing medicine for over 17 years. Dr. Weathers is rated as an Elite provider by MediFind in the treatment of Gliosarcoma. She is also highly rated in 22 other conditions, according to our data. Her clinical expertise encompasses Astrocytoma, Glioblastoma, Glioma, Brain Tumor, and Awake Craniotomy.

View All Doctors
How do I prevent Gliosarcoma?
There is no known way to prevent gliosarcomas. However, if you develop any symptoms common to a gliosarcoma, it is recommended to make an appointment with your doctor to be properly diagnosed.
What are the latest Gliosarcoma Clinical Trials?
A Phase I Clinical Trial With a Window-of-Opportunity Component of Engineered NK Cells Containing Deleted TGF-ßR2 and NR3C1 in Recurrent Grade 4 Astrocytoma (Glioblastoma)
A Phase I Clinical Trial With a Window-of-Opportunity Component of Engineered NK Cells Containing Deleted TGF-ßR2 and NR3C1 in Recurrent Grade 4 Astrocytoma (Glioblastoma)
Who is this study for: Patients with recurrent glioblastoma
Enrollment Status: Recruiting
Publish Date: September 04, 2026
Intervention Type: Procedure, Biological
Study Drug: Cord Blood-derived Expanded Allogeneic Natural Killer Cells
Study Phase: Phase 1

Summary: This phase I trial is to find out the best dose, possible benefits and/or side effects of engineered natural killer (NK) cells containing deleted TGF-betaR2 and NR3C1 (cord blood \[CB\]-NK-TGF-betaR2-/NR3C1-) in treating patients with glioblastoma that has come back (recurrent). CB-NK-TGF-betaR2-/NR3C1- cells are genetically changed immune cells that may help to control the disease.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Phase 1 Trial of Engineered HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Phase 1 Trial of Engineered HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Who is this study for: Children with recurrent or refractory cerebellar brain tumors
Enrollment Status: Recruiting
Publish Date: September 04, 2026
Intervention Type: Biological
Study Drug: G207
Study Phase: Phase 1

Summary: This study is a clinical trial to determine the safety of inoculating G207 (an experimental virus therapy) into a recurrent or refractory cerebellar brain tumor. The safety of combining G207 with a single low dose of radiation, designed to enhance virus replication, tumor cell killing, and an anti-tumor immune response, will also be tested. Funding Source- FDA OOPD

View All Clinical Trials
What are some Advocacy Organizations?
keep-punching-brain-cancer

Keep Punching supports patients, healthcare providers, and researchers in their fight to prevent and eradicate brain cancer and minimize treatment-related side effects that may adversely impact function and comfort.